Related Experiment Video
Updated: Jul 28, 2026
11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Increase in tacrolimus trough levels after steroid withdrawal
Elly M van Duijnhoven1, Johannes M M Boots, Maarten H L Christiaans
1Department of Internal Medicine, University Hospital of Maastricht, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. evd@groupwise.azm.nl
Summary
Steroid withdrawal significantly increases tacrolimus levels in patients, potentially counteracting immunosuppression goals and increasing serum creatinine. This highlights a critical drug interaction impacting patient management.
Area of Science:
- Pharmacology
- Clinical Medicine
- Drug Interactions
Background:
- Experimental studies suggest glucocorticoids can induce cytochrome P450 3A4 (CYP3A4).
- Clinical data on the interaction between tacrolimus and steroids, specifically prednisolone, is limited.
- Understanding this interaction is crucial for managing immunosuppression and avoiding adverse events.
Purpose of the Study:
- To investigate the clinical impact of prednisolone withdrawal on tacrolimus levels.
- To evaluate the effect of varying prednisolone doses on tacrolimus pharmacokinetics.
- To assess potential consequences of altered tacrolimus exposure after steroid cessation.
Main Methods:
- Retrospective and prospective analysis of tacrolimus trough levels and doses before and after prednisolone withdrawal.
- Dose-normalization of tacrolimus levels for accurate comparison.
- Pharmacokinetic analysis, including area under the curve (AUC), in a subset of patients.
Main Results:
- Tacrolimus dose-normalized levels increased by 11-14% after withdrawing 5 mg prednisolone.
- Tacrolimus dose-normalized levels increased by 33-36% after withdrawing 10 mg prednisolone.
- A significant 18% increase in AUC was observed after 5 mg prednisolone withdrawal, indicating reduced tacrolimus metabolism.
Conclusions:
- Steroid withdrawal leads to increased tacrolimus exposure, potentially reducing the intended decrease in immunosuppression.
- Elevated tacrolimus levels may increase serum creatinine, mimicking signs of organ rejection.
- This interaction necessitates careful monitoring of tacrolimus levels and renal function following steroid withdrawal.
Related Concept Videos
01:15Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Dosage Regimen: Multiple Oral Dosage
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.